People
Protagonist Therapeutics awards stock options to new EVP of clinical operations and pharmacology Suneel Gupta, PhD
17 January 2019 - Biopharmaceutical company Protagonist Therapeutics Inc (Nasdaq:PTGX) on Wednesday announced the grant of stock options to newly appointed executive vice president of clinical operati...
Former Novartis CEO Named Lead Independent Director at Immunsys
16 January 2019 - - US-based clinical stage biotechnology company ImmunSYS has added Douglas G. Watson to its board of directors as lead independent director, the company said.

Watson is ...
ArunA Bio Names Sirgo as Chief Executive Officer
16 January 2019 - - US-based ArunA Bio, a specialist in the development of exosomes for the treatment of CNS and neurodegenerative disorders, has appointed Mark Sirgo, Pharm.D. as chief executive offi...
Phico Therapeutics Names Financial Director, Two Non-Executive Directors
16 January 2019 - - UK-based biotechnology company Phico Therapeutics Ltd has appointed Andrew Armour as financial director, and professor Mark Wilcox and David Beadle as non-executive directors, the ...
Seres Therapeutics Names Shaff as President, Chief Executive Officer
16 January 2019 - - US-based microbiome therapeutics platform company Seres Therapeutics, Inc. (NASDAQ: MCRB) has appointed Eric D. Shaff as president and chief executive officer, the company said.
Berman to Head R and D at Immunocore
16 January 2019 - - UK-based T Cell Receptor biotechnology company Immunocore Ltd has named David Berman as its new head of research and development, the company said.

David joined Immuno...